IMAC HoldingsBACK Pretax Margin % is -14,609.52% as of Sep. 2025. The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, IMAC Holdings ranks worse than 99.85% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. IMAC Holdings's Pre-Tax Income for the
three
months ended in Sep. 2025 was $-3.07 Mil. IMAC Holdings's Revenue for the
three
months ended in Sep. 2025 was $0.02 Mil. Therefore, IMAC Holdings's pretax margin for the quarter that ended in Sep. 2025 was -14,609.52%.
The historical rank and industry rank for IMAC Holdings's Pretax Margin % or its related term are showing as below:
BACK'
s Pretax Margin % Range Over the Past 10 Years
Min: -42269.57 Med: -73.28 Max: -43.18
Current: -42269.57
BACK's Pretax Margin % is ranked worse than 99.85% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 3.97
vs BACK: -42269.57
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
IMAC Holdings Pretax Margin % Related Terms
IMAC Holdings Pretax Margin % Historical Data
* Premium members only.
The historical data trend for IMAC Holdings's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BACK vs FCHS, NHLG, NIVF: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, IMAC Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMAC Holdings Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IMAC Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where IMAC Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMAC Holdings (BACK) has a Pretax Margin % of -14,609.52% as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on IMAC Holdings and its competitors. According to the industry distribution chart, IMAC Holdings ranks #667 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 99.9%.
Is IMAC Holdings' Pretax Margin % too high?
IMAC Holdings' current Pretax Margin % is -14,609.52%. Based on the distribution chart, IMAC Holdings ranks #667 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does IMAC Holdings' Pretax Margin % compare to FCHS and NHLG?
According to the Healthcare Providers & Services industry distribution chart, IMAC Holdings ranks #667 out of 668 companies for Pretax Margin %. This places IMAC Holdings in the lower half of its industry. The industry median Pretax Margin % is 3.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 3.97, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on IMAC Holdings and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 3.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMAC Holdings's current Pretax Margin % is -14,609.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMAC Holdings stock overvalued right now?
IMAC Holdings (BACK) has a current Pretax Margin % of -14,609.52%. The current Pretax Margin % is -14,609.52%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For IMAC Holdings (BACK), the current Pretax Margin % is -14,609.52% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IMAC Holdings Inc is engaged in providing services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, located in a single geographic location, the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BACK has been successfully added to your 